Trxade Group Inc (OTCMKTS:TRXD – Get Rating)’s share price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.41 and traded as low as $1.07. Trxade Group shares last traded at $1.16, with a volume of 287,771 shares traded.
Trxade Group Price Performance
The company has a quick ratio of 4.45, a current ratio of 4.51 and a debt-to-equity ratio of 0.26. The firm has a market cap of $45.51 million, a P/E ratio of -404.00 and a beta of 1.35. The business has a fifty day moving average of $1.41 and a 200 day moving average of $1.66.
Trxade Group Company Profile
Trxade Group, Inc owns and operates a business-to-business Web-based marketplace focused on the United States pharmaceutical industry. The company offers Web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com and InventoryRx.com, which are Web-based pharmaceutical marketplaces; Pharmabayonline that provides access to proprietary pharmaceutical data analytics to the United States-based independent pharmacies, pharmaceutical shortage databases, proposed governmental reimbursement benchmarks comparison and analysis, and a proprietary suggested national retail drug benchmark; and RxGuru, a service-based desktop software application, which provides daily drug pricing and analytics to the independent pharmacists.
- Get a free copy of the StockNews.com research report on Trxade Group (TRXD)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Is The Golden Age Of Homebuilding Already Over?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Trxade Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trxade Group and related companies with MarketBeat.com's FREE daily email newsletter.